Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Investigative Radiology|November 15, 2019
Gadolinium Retention as a Safety Signal: Experience of a ManufacturerEric Lancelot, Pierre DeschéInvestigative Radiology|March 15, 2019
Assessment of Pharmacokinetic, Pharmacodynamic Profile, and Tolerance of Gadopiclenol, A New High Relaxivity GBCA, in Healthy Subjects and Patients With Brain Lesions (Phase I/IIa Study)Jing Hao, Philippe Bourrinet, Pierre DeschéInvestigative Radiology|May 27, 2020
Future of Diagnostic Computed Tomography: An Update on Physicochemical Properties, Safety, and Development of X-ray Contrast MediaImran Shahid, Eric Lancelot, Pierre DeschéActa Radiologica (Stockholm, Sweden : 1987)|June 14, 2015
Effects of gadolinium-based contrast agent concentrations (0.5 M or 1.0 M) on the diagnostic performance of magnetic resonance imaging examinations: systematic review of the literatureEric Lancelot, John Froehlich, Oliver Heine, et al.Investigative Radiology|August 11, 2020
Current and Future MR Contrast Agents: Seeking a Better Chemical Stability and Relaxivity for Optimal Safety and EfficacyEric Lancelot, Jean-Sébastien Raynaud, Pierre DeschéBritish Journal of Clinical Pharmacology|April 18, 2020
Randomized study of the effect of gadopiclenol, a new gadolinium-based contrast agent, on the QTc interval in healthy subjectsChristian Funck-Brentano, Mathieu Felices, Nathalie Le Fur, et al.Investigative Radiology|August 10, 2016
Adverse Reactions to Gadoterate Meglumine: Review of Over 25 Years of Clinical Use and More Than 50 Million DosesEric de Kerviler, Kenneth Maravilla, Jean-François Meder, et al.Pageof 1